Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2020-01-17 | 2020-02-07 | 103569 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2020-03-12 | 2020-05-14 | 108613 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2022-04-21 | 2022-08-20 | 159195 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2022-05-12 | 2022-08-20 | 160439 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2023-10-19 | 2023-12-07 | 207524 |
| TEVA-ALENDRONATE/CHOLECALCIFEROL | 70MG 2800UNIT | TABLET | Actual shortage | 2017-09-22 | 2018-12-21 | 23143 |
| TEVA-ALENDRONATE/CHOLECALCIFEROL | 70MG 5600UNIT | TABLET | Actual shortage | 2017-09-22 | 2018-12-21 | 23146 |
| TEVA-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2017-08-21 | 2019-08-29 | 19922 |
| TEVA-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2023-01-12 | 2023-06-21 | 180894 |
| TEVA-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2024-06-07 | 2025-06-17 | 229966 |
| TEVA-ALPRAZOLAM | 0.5MG | TABLET | Resolved | 2023-01-12 | 2023-04-28 | 180897 |
| TEVA-AMIODARONE | 200MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110664 |
| TEVA-AMIODARONE | 200MG | TABLET | Resolved | 2020-10-15 | 2020-11-07 | 126519 |
| TEVA-AMIODARONE | 200MG | TABLET | Resolved | 2022-06-16 | 2022-09-23 | 162849 |
| TEVA-AMIODARONE | 200MG | TABLET | Resolved | 2025-08-29 | 2025-10-16 | 266181 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2017-03-14 | 2018-03-08 | 2427 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2017-03-14 | 2017-05-23 | 2434 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2017-03-14 | 2017-05-23 | 2437 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2017-04-03 | 2018-03-08 | 5171 |
| TEVA-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42619 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |